NORETHINDRONE AND ETHINYL ESTRADIOL

Post-LOE

ethinyl estradiol; norethindrone

Viatris (2)

ANDAORAL-28TABLET

Approved

Aug 2013

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

3/8 — Basic

NORETHINDRONE AND ETHINYL ESTRADIOL (ethinyl estradiol; norethindrone) by Viatris (2). Approved for pregnancy. First approved in 2013.

Drug data last refreshed 18h ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (1)

pregnancy

Clinical Trials (1)

NCT01953809Phase 1Withdrawn

A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

Started Aug 2014

Infections, Bacterial

Company

Worked on NORETHINDRONE AND ETHINYL ESTRADIOL at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.